Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/8/2025

Medications That Cause Kidney Stones

Direct Stone-Forming Medications

  • Indinavir is the most notorious antiretroviral for causing nephrolithiasis, with crystalluria occurring in 20% of treated patients and symptomatic stones being a major side effect 1
  • Indinavir stones form due to pH-dependent solubility in urine, with risk factors including low lean-body mass, doses of 1000 mg twice daily, and concomitant trimethoprim-sulfamethoxazole use 1
  • Ritonavir-boosted indinavir regimens increase nephrolithiasis risk through higher peak drug concentrations 1
  • Sulfonamides cause intratubular crystal precipitation leading to acute renal failure, particularly sulfadiazine used for cerebral toxoplasmosis 1
  • Ciprofloxacin causes intratubular crystal precipitation; avoidance of rapid intravenous bolus and adequate hydration are essential 1
  • Acyclovir causes intratubular crystal precipitation and acute renal failure when given as rapid intravenous bolus without adequate hydration 1
  • Foscarnet similarly causes crystal-induced acute renal failure and requires hydration and dose adjustment for renal dysfunction 1

Critical Prevention Strategies

  • Daily intake of at least 1.5 liters of water prevents stone formation, particularly in high-risk patients 1
  • Avoid rapid intravenous bolus administration of acyclovir, ciprofloxacin, and foscarnet 1
  • Adjust doses for renal dysfunction in patients receiving potentially nephrotoxic medications 1
  • Monitor for crystalluria in patients taking indinavir, with urinalysis showing pyuria even without visible crystals 1

Monitoring and Risk Assessment

  • Environmental conditions (temperature, atmospheric pressure, humidity) affect indinavir nephrolithiasis risk 1
  • Coinfection with hepatitis B or C increases risk of indinavir-related stones 1

Medications That Can Cause Kidney Stones

Introduction to Kidney Stone Risk

  • Clinicians should routinely query patients about stone-provoking medications and supplements during evaluation for kidney stones, as certain drugs directly increase stone formation risk through crystallization in urine or metabolic effects 2, 3

Metabolic Disruptors and Kidney Stone Risk

  • Calcium supplements (as opposed to dietary calcium) may increase stone risk 4
  • Diuretics (certain types) can alter renal blood flow and intrarenal hemodynamics 5

Prevention and Monitoring Strategies

  • Patients on stone-forming medications should maintain urine output of at least 2 liters daily to lower concentration of crystallizing substances 6
  • Monitor high-risk patients more closely with periodic urinalysis and imaging 2